Mutual Fund Ownership
Ownership as on: Wed, 17 Jul, 2024

Kotak Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)8.75
% of AUM2.84%

UTI Healthcare Fund Regular Plan Growth

NA
Equity
Amount Invested (Cr.)14.28
% of AUM1.45%

UTI Small Cap Fund Regular Growth

2/5
Equity
Amount Invested (Cr.)45.41
% of AUM1.08%

UTI Large & Mid Cap Fund Regular Plan Growth

3/5
Equity
Amount Invested (Cr.)27.05
% of AUM0.79%

UTI Aggressive Hybrid Fund Regular Plan Growth

4/5
Hybrid
Amount Invested (Cr.)41.19
% of AUM0.70%

FAQs about Marksans Pharma share price

Marksans Pharma is trading at 186.65 as on Tue Jul 16 2024 09:59:00. This is -0.48% lower as compared to its previous closing price of 187.55.

The market capitalization of Marksans Pharma is 8458.30 Cr as on Tue Jul 16 2024 09:59:00.

The 52 wk high for Marksans Pharma is 197.15 whereas the 52 wk low is 93.85

Marksans Pharma can be analyzed on the following key metrics -

  • TTM P/E: 21.92
  • Sector P/E: 29.82
  • Dividend Yield: 0.32%
  • D/E ratio: 0.12

Marksans Pharma reported a net profit of 313.70 Cr in 2024.

Recommended For You
Trending Stocks
2,689.65+70.75(2.70%)
1,466.00+28.80(2.00%)
1,515.80+16.95(1.13%)
1,805.20-38.95 (-2.11%)
380.45-5.20 (-1.35%)
HomeMarketsPremiumInstant LoanMint Shorts